The most expedient way to test Johnson and Johnson’s experimental Ebola vaccine is to administer it during an outbreak, which is the way Merck’s vaccine was successfully deployed in Guinea in 2015. Locally, however, there are fears people in the Congo could be used as guinea pigs.